Technical Analysis for MBIO - Mustang Bio, Inc.

Grade Last Price % Change Price Change
grade D 4.47 3.71% 0.16
MBIO closed up 3.71 percent on Friday, February 15, 2019, on 1.28 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Flat
See historical MBIO trend table...

Date Alert Name Type % Chg
Feb 15 Calm After Storm Range Contraction 0.00%
Feb 15 Wide Bands Range Expansion 0.00%
Feb 14 1,2,3 Pullback Bullish Bullish Swing Setup 3.71%
Feb 14 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.71%
Feb 14 Calm After Storm Range Contraction 3.71%
Feb 14 Wide Bands Range Expansion 3.71%
Feb 13 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Feb 13 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Feb 13 Calm After Storm Range Contraction 0.00%
Feb 13 Wide Bands Range Expansion 0.00%

Older signals for MBIO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Mustang Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to utilize the power of the patient’s own immune system to eliminate cancer cells. It seeks to acquire rights to technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development and eventually either out-licensing or bringing the technologies to market. The Company is developing its proprietary Chimeric Antigen Receptor (CAR) engineered T cells (CAR -T) technology, which uses the patient’s own T cells to engage and destroy specific tumors. The Company, through its agreement with City of Hope National Medical Center, is using three novel CAR T therapies in the development of cancer treatments, including human epidermal growth factor receptor 2 CAR T technology, CS1-specific CAR T technology, and prostate stem cell antigen CAR T technology.
Medicine Biopharmaceutical Cancer Immunotherapy Immune System Cancer Treatments Gene Therapy Cancer Immunotherapy Virotherapy Kite Pharma Chimeric Antigen Receptor Cancer Immunotherapy Products Cellectis T Cell
Is MBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 11.99
52 Week Low 2.18
Average Volume 85,081
200-Day Moving Average 5.5567
50-Day Moving Average 3.3624
20-Day Moving Average 3.862
10-Day Moving Average 4.467
Average True Range 0.4766
ADX 40.18
+DI 35.2491
-DI 10.4271
Chandelier Exit (Long, 3 ATRs ) 4.8902
Chandelier Exit (Short, 3 ATRs ) 4.3398
Upper Bollinger Band 5.298
Lower Bollinger Band 2.426
Percent B (%b) 0.71
BandWidth 74.365614
MACD Line 0.3654
MACD Signal Line 0.3116
MACD Histogram 0.0538
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.18
Resistance 3 (R3) 5.16 4.92 5.06
Resistance 2 (R2) 4.92 4.74 4.92 5.02
Resistance 1 (R1) 4.69 4.63 4.81 4.71 4.98
Pivot Point 4.45 4.45 4.50 4.45 4.45
Support 1 (S1) 4.22 4.27 4.34 4.24 3.96
Support 2 (S2) 3.98 4.16 3.98 3.92
Support 3 (S3) 3.75 3.98 3.88
Support 4 (S4) 3.77